Peginterferon lambda
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Peginterferon lambda, covering 2022-04-05 to 2023-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV [Phase 3]